Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation ; volume:20 ; number:1 ; day:6 ; month:7 ; year:2022 ; pages:1-12 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (6.7.2022), 1-12, 12.2022
- Urheber
-
Xu, Dan
Chen, Yishan
Yang, Ying
Yin, Zhao
Huang, Changfen
Wang, Qiang
Jiang, Ling
Jiang, Xuejie
Yin, Changxin
Liu, Qifa
Yu, Guopan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-022-03498-1
- URN
-
urn:nbn:de:101:1-2022082521243248928545
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-15T07:30:16+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, Dan
- Chen, Yishan
- Yang, Ying
- Yin, Zhao
- Huang, Changfen
- Wang, Qiang
- Jiang, Ling
- Jiang, Xuejie
- Yin, Changxin
- Liu, Qifa
- Yu, Guopan
- SpringerLink (Online service)
Ähnliche Objekte (12)
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Paradoxical carbon dioxide embolism during laparoscopic nephrectomy
Prevalence, Risk Factors, and Prognostic Value of Anxiety and Depression in Acute Myeloid Leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Effekte von FLT3-ITD Inhibitoren auf Chemotherapie resistente AML Zelllinien
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Paradoxical carbon dioxide embolism during laparoscopic nephrectomy
Prevalence, Risk Factors, and Prognostic Value of Anxiety and Depression in Acute Myeloid Leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Effekte von FLT3-ITD Inhibitoren auf Chemotherapie resistente AML Zelllinien
FLT3-ITD regulated miRs in AML
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Role of FLT3 ITD PTPRC signaling in bone remodeling
The role of STAT5 in FLT3-ITD-mediated leukemogenesis
Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML
Paradoxical carbon dioxide embolism during laparoscopic nephrectomy
Prevalence, Risk Factors, and Prognostic Value of Anxiety and Depression in Acute Myeloid Leukemia
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations